Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)

Trial Identifier:	D1843R00345
Sponsor:	AstraZeneca
NCTID::	NCT06099067
Start Date:	May 2020
Primary Completion Date:	August 2023
Study Completion Date:	August 2023
Condition:	Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Sweden	Gothenburg, Sweden, 43183

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.